On the other hand, Noda et al. reported that CD34+THY1+ fibroblasts exhibit high osteoblast and chondrocyte differentiation potential (32), thus whether this CD34+ subset promotes or inhibits the pathogenesis of OA and RA has been left unresolved. The gene discussed is CD34; the disease is rheumatoid arthritis.